TECH

Bio-Techne Corp (TECH)

Healthcare • NASDAQ$48.36-5.01%

Key Fundamentals
Symbol
TECH
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$48.36
Daily Change
-5.01%
Market Cap
$7.57B
Trailing P/E
69.09
Forward P/E
23.40
52W High
$72.16
52W Low
$45.12
Analyst Target
$62.64
Dividend Yield
+0.66%
Beta
1.41
About Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifyi

Company website

Research TECH on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Terms · Privacy · ·

Loading...